Biotech Arcutis Announces Arcutis Cares(TM) Patient Assistance Program (PAP) For Financially Qualified Uninsured and Underinsured Patients August 23, 2022
Biotech Veru Granted Expedited Provisional Registration Regulatory Pathway for Sabizabulin Treatment in Hospitalized COVID-19 Patients by Australia’s Therapeutic Goods Administration August 23, 2022
Biotech REGENXBIO Announces Presentations at the Society for the Study of Inborn Errors of Metabolism Annual Symposium August 23, 2022
Biotech Arcutis Completes Enrollment in INTEGUMENT-2 Pivotal Phase 3 Trial of Ro?umilast Cream in Atopic Dermatitis August 23, 2022
Biotech Veru Announces Appointment of Jason Davies to Lead EMEA, LATAM and APAC Infectious Disease Franchise for Veru International Focused on Hospitalized COVID-19 Patients August 22, 2022
Biotech FDA Accepts Krystal Biotech’s Biologics License Application for Dystrophic Epidermolysis Bullosa August 19, 2022
Biotech SpringWorks Therapeutics Announces Late-Breaking Oral Presentation of Phase 3 DeFi Data at the European Society for Medical Oncology (ESMO) Congress 2022 August 19, 2022
Biotech BridgeBio Pharma Announces Dosing of First Patient in Phase 1 Trial of BBP-671, a Potential Best-In-Class Treatment for Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA) August 18, 2022
Biotech NGM Bio Provides Business Highlights and Reports Second Quarter 2022 Financial Results August 18, 2022
Search
Biotech
August 23, 2022
August 23, 2022
August 23, 2022
August 23, 2022
August 22, 2022
August 19, 2022
August 19, 2022
August 19, 2022
August 18, 2022
August 18, 2022
